The effect of agnogl on oligomenorrhea in polycystic ovary syndrome
- Conditions
- Oligomenorrhea.-
- Registration Number
- IRCT2015072623350N1
- Lead Sponsor
- Vice Chancellor for research, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 120
being married; Being pregnant; There oligomenorrhea; No known physical or mental illness confirmed by a psychiatrist; Not taking any hormonal medication to treat menstrual disorders in the last three months; No history of allergies to herbal medicines; No drugs affecting the menstrual cycle; Not taking anti-androgen drugs and combinations of estrogen and progesterone secretion and insulin action and insulin and drugs affecting between 1 month before the survey; No history of liver disease, kidney, cardiovascular, diabetes Exclusion criteria: taking any medications that affect the menstrual cycle; Allergy medication; Drugs and oral contraceptives; Androgen-secreting tumors, high blood prolactin; Unwillingness to cooperate in the project
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improve oligomenorrhea. Timepoint: Before, 3 months after intervention. Method of measurement: Check list.
- Secondary Outcome Measures
Name Time Method